Global Bioenergies (ALGBE) Stock Overview
Engages in the development of a process for converting plant-based feedstocks into isobutene used in the cosmetic and aviation fuel industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ALGBE Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Global Bioenergies SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.018 |
| 52 Week High | €1.57 |
| 52 Week Low | €0.017 |
| Beta | 0.29 |
| 1 Month Change | -13.95% |
| 3 Month Change | -42.55% |
| 1 Year Change | -97.86% |
| 3 Year Change | -99.52% |
| 5 Year Change | -99.77% |
| Change since IPO | -99.93% |
Recent News & Updates
Recent updates
Is Global Bioenergies (EPA:ALGBE) Using Too Much Debt?
May 21
Global Bioenergies SA's (EPA:ALGBE) Intrinsic Value Is Potentially 60% Above Its Share Price
Sep 18Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?
Jun 21Is Global Bioenergies (EPA:ALGBE) Using Debt Sensibly?
Jun 28Global Bioenergies (EPA:ALGBE) Has Debt But No Earnings; Should You Worry?
Oct 11Does Global Bioenergies (EPA:ALGBE) Have A Healthy Balance Sheet?
Oct 25Global Bioenergies (EPA:ALGBE) Shareholders Have Enjoyed An Impressive 187% Share Price Gain
Mar 20Shareholder Returns
| ALGBE | FR Chemicals | FR Market | |
|---|---|---|---|
| 7D | -5.6% | -0.4% | 1.7% |
| 1Y | -97.9% | 3.0% | 11.5% |
Return vs Industry: ALGBE underperformed the French Chemicals industry which returned 3.3% over the past year.
Return vs Market: ALGBE underperformed the French Market which returned 11.9% over the past year.
Price Volatility
| ALGBE volatility | |
|---|---|
| ALGBE Average Weekly Movement | 23.0% |
| Chemicals Industry Average Movement | 4.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in FR Market | 10.6% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALGBE's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: ALGBE's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 43 | Marc Delcourt | www.global-bioenergies.com |
Global Bioenergies SA engages in the development of a process for converting plant-based feedstocks into isobutene used in the cosmetic and aviation fuel industry. The company also offers engineering services in gas fermentation process. In addition, it develops a process to convert gaseous carbon sources, such as CO2, CO, and industrial emissions comprising syngas into various chemical compounds.
Global Bioenergies SA Fundamentals Summary
| ALGBE fundamental statistics | |
|---|---|
| Market cap | €335.38k |
| Earnings (TTM) | -€5.86m |
| Revenue (TTM) | €360.66k |
Is ALGBE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALGBE income statement (TTM) | |
|---|---|
| Revenue | €360.66k |
| Cost of Revenue | €849.18k |
| Gross Profit | -€488.52k |
| Other Expenses | €5.37m |
| Earnings | -€5.86m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.32 |
| Gross Margin | -135.45% |
| Net Profit Margin | -1,625.06% |
| Debt/Equity Ratio | 334.1% |
How did ALGBE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/28 20:56 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Global Bioenergies SA is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Markus Mayer | Baader Helvea Equity Research |
| Mark Cartlich | Edison Investment Research |
| Alexandre Letz | Gilbert Dupont |